MedTrace Logo

Focused-PPC: An Integrated Postpartum Care, Education, and Support Model for Women in Ghana

NCT05280951 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2022-03-15

No results posted yet for this study

Summary

The purpose of this project is to test and evaluate an innovative postpartum care, education, and support model that integrates recommended clinical care, education, and support for women in a group setting.

Aim 1. Develop an innovative integrated group postpartum care, education, and support model entitled Focused-PPC for postpartum women up to one year after delivery.

Aim 2. Implement and evaluate this integrated postpartum care model entitled Focused-PPC in a parallel randomized controlled trial with 192 postpartum women at 4 health centers in Tamale, Ghana.

Conditions

  • Postpartum Care

Interventions

OTHER

Focused-PPC Care

Individual clinical assessments and counseling for each group member will last about 15 minutes. Then, there will be 1 hour of group time dedicated to education and support. Each group session will be led by two trained and registered midwives who will provide both clinical care, education, and support as needed. In addition, each group session will be supported by a project assistant. Focused-PPC will be implemented in addition to newborn care.

OTHER

Usual Care

Women in the control group will receive standard postnatal care (PNC) currently practiced in the health centers. This involves attending PNC visits at the health center within 14 days after birth, at 6 weeks, and monthly thereafter up to one year.

Sponsors & Collaborators

  • Savana Signatures

    collaborator UNKNOWN

  • Indiana University School of Medicine

    collaborator OTHER

  • University of Notre Dame

    lead OTHER

Principal Investigators

  • Yenupini J Adams, PhD, BSN · University of Notre Dame

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-26
Primary Completion
2023-01-31
Completion
2023-06-30

Countries

  • Ghana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05280951 on ClinicalTrials.gov